Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Cempra Pharmaceuticals completes its Series A round

Executive Summary

Cempra Pharmaceuticals (developing therapeutics to treat drug-resistant bacteria in the hospital and at home) has raised $22mm with its Series A venture round. Intersouth Partners and I. Wistar Morris, III (an investment banker) co-led the financing and were joined by new backer Aisling Capital.

Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Large Molecule
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies